Work package 7

Studying the implementation of the behavioural program developed in WP6

Work Package leader: Prof. Herman Goossens, University of Antwerp  
 


Objectives

To explore problems related to the implementation of the CHAMP behavioural program aiming at a more rational use of antibiotics in three different European regions (six countries)

Description of work
The development of an instrument should be followed by field testing and assessment of its effect in daily practice. As said before this WP will be done in close collaboration with WP10 of the GRACE project. The behavioural program will be implemented in the GRACE networks. The actual effectiveness of the intervention will be a deliverable of the GRACE project. CHAMP will only study feasibility of the intervention. Within WP7 the CHAMP behavioural program will be implemented in six European national primary care networks. The networks will be spread over the different parts of Europe: two networks in Northern Europe, two in Eastern Europe and two in Southern Europe. This implementation will be done in close collaboration with the GRACE Network of Excellence program. Within each national network 15 practices will be randomly selected for implementation of the behavioural program to be defined in WP6. The program will be confined to rationalising antibiotic use in adults and children with lower respiratory tract infections. As also indicated in the GRACE proposal, most likely we will use academic detailing/outreach since the existing evidence from Cochrane reviews about behaviour change suggests this method is likely to be the most effective.   Facilitators will be trained centrally at specially arranged training days until they are competent and confident in using the behavioural program. A small publication relation company with extensive experience in public health care will support both the development of the intervention and the implementation strategy in this workpackage. Analysis of the target population (primary care physicians and particular patients groups) will be done based on information of the other workpackages and tools will be developed to communicate the key messages. Within this WP7 we will study the feasibility of the implementation of the behavioural program and possible problems associating with measuring antibiotic use in the different national settings. This will be done by measuring time and costs associated with the implementation and measuring of antibiotic use. In addition, experiences of both health care workers and patients will be measured by way of standardized evaluations in daily practice and surveys.

Studying the implementation of the behavioural program developed in WP6

Work Package leader: Prof. Herman Goossens, University of Antwerp  
 


Objectives

To explore problems related to the implementation of the CHAMP behavioural program aiming at a more rational use of antibiotics in three different European regions (six countries)

Description of work
The development of an instrument should be followed by field testing and assessment of its effect in daily practice. As said before this WP will be done in close collaboration with WP10 of the GRACE project. The behavioural program will be implemented in the GRACE networks. The actual effectiveness of the intervention will be a deliverable of the GRACE project. CHAMP will only study feasibility of the intervention. Within WP7 the CHAMP behavioural program will be implemented in six European national primary care networks. The networks will be spread over the different parts of Europe: two networks in Northern Europe, two in Eastern Europe and two in Southern Europe. This implementation will be done in close collaboration with the GRACE Network of Excellence program. Within each national network 15 practices will be randomly selected for implementation of the behavioural program to be defined in WP6. The program will be confined to rationalising antibiotic use in adults and children with lower respiratory tract infections. As also indicated in the GRACE proposal, most likely we will use academic detailing/outreach since the existing evidence from Cochrane reviews about behaviour change suggests this method is likely to be the most effective.   Facilitators will be trained centrally at specially arranged training days until they are competent and confident in using the behavioural program. A small publication relation company with extensive experience in public health care will support both the development of the intervention and the implementation strategy in this workpackage. Analysis of the target population (primary care physicians and particular patients groups) will be done based on information of the other workpackages and tools will be developed to communicate the key messages. Within this WP7 we will study the feasibility of the implementation of the behavioural program and possible problems associating with measuring antibiotic use in the different national settings. This will be done by measuring time and costs associated with the implementation and measuring of antibiotic use. In addition, experiences of both health care workers and patients will be measured by way of standardized evaluations in daily practice and surveys.

Herman Goossens